Biocardia reports third quarter 2023 business highlights and financial results

Sunnyvale, calif., nov. 08, 2023 (globe newswire) -- biocardia, inc. [nasdaq: bcda], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reports financial results for the third quarter of 2023 and filed its quarterly report on form 10-q for the three and nine months ended june 30, 2023 with the securities and exchange commission. the company will also hold a conference call at 4:30 pm et today in which it will discuss business highlights.  following management's formal remarks, there will be a question-and-answer session.
BCDA Ratings Summary
Quant
BCDA Quant Ranking
Sector
Industry
Quant Rating
Quant Score